FAKTOR YANG MEMPENGARUHI PERTUMBUHAN, PERKEMBANGAN, DAN KUALITAS HIDUP

PASIEN TRISOMI 21 DENGAN PDA

BESAR, HIPERTENSI PULMONAL, HIPOTIROID, GLOBAL DEVELOPMENTAL DELAYED, DAN GIZI
KURANG
RAHMA ANINDITA, dr. Indah Kartika Murni, Ph.D Sp.AK.; Dr. dr. Titis Widowati, Sp.AK
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

DAFTAR PUSTAKA
1. Kawanto FH, Soedjatmiko S. Pemantauan Tumbuh Kembang Anak dengan
Sindrom Down. Sari Pediatr [Internet]. 2016;9:185. Available from:
https://saripediatri.org/index.php/sari-pediatri/article/view/739
2. Kumar S, Ghosh S. 2011. Etiology of Down Syndrome: Risk of Advanced
Maternal Age and Altered Meiotic Recombination for Chromosome 21
Nondisjunction. In: Genetics and Etiology of Down Syndrome.
London:InTechOpen publisher.
3. Wexler ID, Abu-Libdeh A, Kastiel Y, Nimrodi A, Kerem E, Tenenbaum A.
Optimizing health care for individuals with Down syndrome in Israel. Isr
Med Assoc J. 2009;11:655–9.
4. Espinola-Zavaleta N, Soto ME, Romero-Gonzalez A, del Carmen Gómez-
Puente L, Muñoz-Castellanos L, Gopal AS, et al. Prevalence of Congenital
Heart Disease and Pulmonary Hypertension in Down’s Syndrome: An
Echocardiographic Study. J Cardiovasc Ultrasound. 2015;23:72.
5. Hardy O, Worley G, Lee MM, Chaing S, Mackey J, Crissman B, et al.
Hypothyroidism in Down syndrome: Screening guidelines and testing
methodology. Am J Med Genet. 2004;124A:436–7.
6. Road H, Bray E. 2010. An overview of the development of infants with Down
syndrome. England and Wales: Down Syndrome Education International.
7. Cannalire G, Bellini M. The Importance of Knowing Growth and Pubertal
Development in Down Syndrome. J Clin Case Reports. 2016;5:11–3.
8. Bull MJ. Health Supervision for Children With Down Syndrome. Pediatrics.
2011;128:393–406.
9. Sheets KB, Crissman BG, Feist CD, Sell SL, Johnson LR, Donahue KC, et al.
Practice guidelines for communicating a prenatal or postnatal diagnosis of
down syndrome: Recommendations of the National Society of Genetic
Counselors. J Genet Couns. 2011;20:432–41.
10. Mai CT, Kucik JE, Isenburg J, Feldkamp ML, Marengo LK, Bugenske EM,
et al. Selected birth defects data from population-based birth defects

57
 FAKTOR YANG MEMPENGARUHI PERTUMBUHAN, PERKEMBANGAN, DAN KUALITAS HIDUP
PASIEN TRISOMI 21 DENGAN PDA
BESAR, HIPERTENSI PULMONAL, HIPOTIROID, GLOBAL DEVELOPMENTAL DELAYED, DAN GIZI
58
KURANG
RAHMA ANINDITA, dr. Indah Kartika Murni, Ph.D Sp.AK.; Dr. dr. Titis Widowati, Sp.AK
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

surveillance programs in the United States, 2006 to 2010: Featuring trisomy

conditions. Birth Defects Res Part A - Clin Mol Teratol. 2013;97:709–25.
11. Gersak K, M. D, Pohar-Perme M. 2013. Increased Fetal Nuchal Translucency
Thickness and Normal Karyotype: Prenatal and Postnatal Outcome. In: Down
Syndrome. London:InTechOpen publisher.
12. Kazemi M, Salehi M, Kheirollahi M. Down Syndrome: Current Status,
Challenges and Future Perspectives. Int J Mol Cell Med. 2016;5:125–33.
13. Cebeci AN, Güven A, Yildiz M. Profile of hypothyroidism in Down’s
syndrome. J Clin Res Pediatr Endocrinol. 2013;5:116–20.
14. Purdy IB, Singh N, Brown WL, Vangala S, Devaskar UP. Revisiting early
hypothyroidism screening in infants with Down syndrome. J Perinatol.
2014;34:936–40.
15. Bermudez BEBV, Medeiros SL, Bermudez MB, Novadzki IM, Magdalena
NIR. Down syndrome: Prevalence and distribution of congenital heart disease
in Brazil. São Paulo Med J. 2015;133:521–4.
16. Arlettaz R. Echocardiographic Evaluation of Patent Ductus Arteriosus in
Preterm Infants. Front Pediatr. 2017;5:1–9.
17. Schneider DJ, Moore JW. Patent Ductus Arteriosus. Circulation.
2006;114:1873–82.
18. Annerén G, Gustavson K-H, Sara VR, Tuvemo T. Growth retardation in
Down syndrome in relation to insulin-like growth factors and growth
hormone. Am J Med Genet. 2005;37:59–62.
19. Bravo-Valenzuela NJ, Passarelli ML, Coates M V, Nascimento LF. Weight
and height recovery in children with Down syndrome and congenital heart
disease. Rev Bras Cir Cardiovasc. 2011;26:61–8.
20. Holmes G. Gastrointestinal disorders in Down syndrome. Gastroenterol
Hepatol from Bed to Bench. 2014;7:6–8.
21. O. C, F. O, C. G, T. C, S. A, F. O, et al. Celiac disease in children with down
syndrome: Importance of follow-up and serologic screening. Pediatr Int.
2003;45:395–9.
22. AO D, MJ B, Casey-Harvey D, RT M, ML P, JJ R, et al. Down syndrome: a
 FAKTOR YANG MEMPENGARUHI PERTUMBUHAN, PERKEMBANGAN, DAN KUALITAS HIDUP
PASIEN TRISOMI 21 DENGAN PDA
BESAR, HIPERTENSI PULMONAL, HIPOTIROID, GLOBAL DEVELOPMENTAL DELAYED, DAN GIZI
59
KURANG
RAHMA ANINDITA, dr. Indah Kartika Murni, Ph.D Sp.AK.; Dr. dr. Titis Widowati, Sp.AK
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

multidisciplinary perspective. J Am Acad Audiol. 1995;6:39–46.

23. Mik G, Gholve PA, Scher DM, Widmann RF, Green DW. Down syndrome:
Orthopedic issues. Curr Opin Pediatr. 2008;20:30–6.
24. Charleton PM, Dennis J, Marder E. Medical management of children with
Down syndrome. Paediatr Child Health (Oxford). 2010;20:331–7.
25. Bassell JL, Phan H, Leu R, Kronk R, Visootsak J. Sleep profiles in children
with down syndrome. Am J Med Genet Part A. 2015;167:1830–5.
26. Watts R, Vyas H. An overview of respiratory problems in children with
down’s syndrome. Arch Dis Child. 2013;98:812–7.
27. Hyo In Kim, Seong Woo Kim, Jiyong Kim, Ha Ra Jeon, Da Wa Jung. Motor
and Cognitive Developmental Profiles in Children With Down Syndrome.
Ann Rehabil Med. 2017;41:97–103.
28. Hassan BA, Albanna EA, Morsy SM, Siam AG, Al Shafie MM, Elsaadany
HF, et al. Nutritional Status in Children with Un-Operated Congenital Heart
Disease: An Egyptian Center Experience. Front Pediatr. 2015;3:1–5.
29. Daymont C, Neal A, Prosnitz A, Cohen MS. Growth in children with
congenital heart disease. Pediatr Cardiol. 2013;34:1296–7.
30. Togănel R. Nutritional Approach of Pediatric Patients Diagnosed with
Congenital Heart Disease. Acta Medica Marisiensis. 2013;59:121–5.
31. Saranac L, Stamenkovic H, Stankovic T, Radovanovic Z, Zivanovic S, Djuric
Z. 2013. Growth in Children with Thyroid Dysfunction. In: Current Topics in
Hypothyroidism with Focus on Development. London:InTechOpen publisher.
32. Myrelid A. 2009. Down Syndrome Growth and Endocrine Impact. Acta
Universitatis Upsaliensis. Digital Comprehensive Summaries of Uppsala
Dissertations fro the Faculty of Medicine 465.
33. Allen LH. Animal source foods to improve micronutrient nutrition and human
function in developing countries: Past, Present and Future. J Nutr.
2003;133:3875–4061.
34. DeBoer MD, Scharf RJ, Leite AM, Férrer A, Havt A, Pinkerton R, et al.
Systemic inflammation, growth factors, and linear growth in the setting of
infection and malnutrition. Nutrition. 2017;33:248–53.
 FAKTOR YANG MEMPENGARUHI PERTUMBUHAN, PERKEMBANGAN, DAN KUALITAS HIDUP
PASIEN TRISOMI 21 DENGAN PDA
BESAR, HIPERTENSI PULMONAL, HIPOTIROID, GLOBAL DEVELOPMENTAL DELAYED, DAN GIZI
60
KURANG
RAHMA ANINDITA, dr. Indah Kartika Murni, Ph.D Sp.AK.; Dr. dr. Titis Widowati, Sp.AK
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

35. Cole SZ, Lanham JS. Failure to thrive: an update. Am Fam Physician.
2011;83:829–34.
36. Zhang J, Guo S, Li Y, Wei Q, Zhang C, Wang X, et al. Factors influencing
developmental delay among young children in poor rural China: A latent
variable approach. BMJ Open. 2018;8:1–9.
37. Ferreira-Vasques At, Lamonica DAC. Motor, linguistic, personal and social
aspects of children with Down syndrome. J Appl Oral Sci. 2015;23:424–30.
38. Prado EL, Dewey KG. Nutrition and brain development in early life. Nutr
Rev. 2014;72:267–84.
39. NYSDOH. 2006. Report of the recommendations: Down syndrome
assessment and intervention for young children (Age 0-3 years). New
York:New York State Department of Health.
40. Tsang R, Shekerdemian LS. Patent Ductus Arteriosus and the Immature
Brain: Is Early Intervention Protective? Pediatrics. 2016;137:e20154659–
e20154659.
41. Haddad F, Bourke J, Wong K, Leonard H. An investigation of the
determinants of quality of life in adolescents and young adults with Down
syndrome. PLoS One. 2018;13:1–19.
42. Abd El-Hady SS, Abd El-Azim FH, El-Talawy HAEAM. Correlation
between cognitive function, gross motor skills and health – Related quality of
life in children with Down syndrome. Egypt J Med Hum Genet. 2018;19:97–
101.
43. Huang Y, Huang Y, Huang D, Liu M, Luo L, Chen J. Reliability of
Echocardiography Measurement of Patent Ductus Arteriosus Minimum
Diameter. IJCDD. 2016;4:15–9.
44. Al-Hamash S, Khalid Z, Wahab H, Nasser I. Transcatheter closure of patent
ductus arteriosus using ADO device: Retrospective study of 149 patients.
Hear Views. 2012;13:1.
45. Counts D, Varma SK. Hypothyroidism in Children. Pediatr Rev.
2009;30:251–8.
46. Pierce MJ, LaFranchi SH, Pinter JD. Characterization of Thyroid
 FAKTOR YANG MEMPENGARUHI PERTUMBUHAN, PERKEMBANGAN, DAN KUALITAS HIDUP
PASIEN TRISOMI 21 DENGAN PDA
BESAR, HIPERTENSI PULMONAL, HIPOTIROID, GLOBAL DEVELOPMENTAL DELAYED, DAN GIZI
61
KURANG
RAHMA ANINDITA, dr. Indah Kartika Murni, Ph.D Sp.AK.; Dr. dr. Titis Widowati, Sp.AK
Universitas Gadjah Mada, 2019 | Diunduh dari http://etd.repository.ugm.ac.id/

Abnormalities in a Large Cohort of Children with Down Syndrome. Horm

Res Paediatr. 2017;87:170–8.
47. Alrahili M, Binyamen A, Al Otaibi F, Alnour AA, Alsaadi M, Aloufi S, et al.
Importance of vaccines in children with Down syndrome. Int J Contemp
Pediatr. 2018;5:1710.
48. Sjarif D, Nasar S, Devaera Y, Tanjung C. 2011. Asuhan nutrisi pediatrik.
Jakarta:Badan Penerbit IDAI.
49. Etemad K, Khazaei Z, Pordanjani SR, Shahsavand M, Ajam F, Riahi S-M, et
al. Evaluation of the therapeutic interventions effects on body growth pattern
of infants with congenital hypothyroidism. Biomed Res Ther. 2018;5:2194–
207.